Our board includes world-renowned experts in clinical operations, biostatistics, regulatory science, and quality assurance — guiding Cyntegrity’s development of evidence-based, inspection-ready solutions.
ETH-Z, Managing Partner Widler & Schiemann Ltd, former Global Head of Clinical Quality at Roche
Advisor on leadership development and organizational resilience with experience in KPMG-affiliated leadership and HR transformation practices.
Scientific Advisory Board, Former CBO; Digital Transformation & RBQM Growth Advisor
Frankfurt Innovation Center (FIZ) — our EU R&D base inside Germany’s largest biotech campus. Take me to the Campus…
LOEWE-funded projects (€1.2 m) advance AI-driven RBQM algorithms now live in > 685 trials. Study the PUEKS 2014 project…
Joint lab validates GxP-ready large-language models with Mannheim Technical University. Watch the Webinar…
Fraunhofer Collaboration — Advancing clinical-trial AI with independent method validation under the LOEWE “AI-TRIAL” initiative (HA-Projekt-Nr.: 2004/25-112).
Novartis provided anonymized study data to support the development of a practical framework for setting and managing Quality Tolerance Limits (QTLs). The resulting academic submission is currently under peer review, with publication expected in Q1 2026.
Collaboratively advancing responsible AI in clinical trials by using Cyntegrity’s Healthcare AI–certified MyRBQM® platform (independent audit commissioned by Microsoft), running on Azure for enterprise-grade security and compliance. Read Our Story…
Let’s explore joint grants, method validation, and real-world RBQM use cases with shared publications.
Featured Insights
Start Your Roll-Out
Quick Answers
